Jimini
Jimini is more than just online therapy:

We have redesigned the entire patient journey, creating a clinically effective, more modern treatment for patients.

What it takes
Science & Technology

Technologies like mRNA, complex antibodies, and cell therapies have improved nearly every aspect of human health in the last 30 years — but therapy and its clinical outcomes have not changed much. Jimini has built a scientifically rigorous, consumer-grade, LLM-augmented experience that is a radical improvement over traditional therapy.

Safe, Clinically Integrated AI

AI and LLMs will impact every aspect of healthcare, including therapy. There are real risks if these technologies are developed without adequate safeguards or clinical integration. In response, Jimini has developed a narrow, specific, and well-validated approach to its AI development. Sage is not a general-purpose chatbot but rather supports the therapist and patient with specialized evidence-based approaches.


Clinically Rigorous, Clinician-Led

World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on truly the most complex parts of their job.

Peer-reviewed research has shown continuous care models produce effect sizes up to 2x greater than conventional online therapy.

Firth, J., Torous, J., Nicholas, J., Carney, R., Rosenbaum, S., & Sarris, J. (2017). Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. Journal of affective disorders, 218, 15-22. Newby et al. (2016). Transdiagnostic computerised cognitive behavioral therapy for depression and anxiety: A systematic review and Meta-analysis
Conventional Therapy Average Effect Size
<.35
Therapy with Transdiagnostic Computerized CBT Effect Size
For Depression .78
For Anxiety .84
Science and tech first

Safe, purpose built patient-facing technology that works exclusively under clinical supervision and high safety standards

Leveraging LLMs and cutting-edge science to develop a radically effective, clinically integrated, and scalable mental health solution

Led by previous biotech AI cofounder and team, and backed by world leaders in Psychology

Outcomes in therapy have not improved much in decades. We are here to develop revolutionary technology and integrated clinical workflows to change that.

Jimini’s leadership team is composed of proven biotech, consumer and academic leaders in psychology, AI, and technology. The team is committed to improve mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.

Executive Team
LUIS VOLOCH
LUIS VOLOCH
Co-Founder & CEO
MARK JACOBSTEIN
MARK JACOBSTEIN
Co-Founder & President
SAHIL SUD
SAHIL SUD
Co-Founder & Chief Product Officer
CHIARA WAINGARTEN
CHIARA WAINGARTEN
Vice President, Business Operations
DR. BILL HUDENKO
DR. BILL HUDENKO
Chief Clinical Officer
LYNN HAMILTON
LYNN HAMILTON
Chief Commercial Officer
OUR ADVISORS
DR. JOHANNES EICHSTAEDT, PHD
DR. JOHANNES EICHSTAEDT, PHD
Stanford University, Assistant Professor (Research) of Psychology
DR. SABINE WILHELM, PHD
DR. SABINE WILHELM, PHD
Harvard Medical School, Professor of Psychology
DR. SETH FEUERSTEIN, MD, JD
DR. SETH FEUERSTEIN, MD, JD
Yale University School of Medicine, Faculty Member
DR. DAVID FEINBERG, MD
DR. DAVID FEINBERG, MD
Oracle Health, Chairman
DEBORAH ADLER, MS
DEBORAH ADLER, MS
Navigator Healthcare Inc., CEO